P3BEP (ANZUP 1302): An International Randomised Phase III Trial of Accelerated Versus Standard BEP Chemotherapy for Adult and Pediatric Male and Female Patients With Intermediate and Poor-Risk Metastatic Germ Cell Tumours (GCTS)

被引:0
|
作者
Wong, Nicole [1 ]
Nayar, Namrata [1 ]
Lawrence, Nicola [1 ]
Stockler, Martin [1 ]
Martin, Andrew [1 ]
Yip, Sonia [1 ]
Yeung, Annie [1 ]
Friedlander, Michael [2 ]
Mazhar, Danish [3 ]
Pashankar, Farzana [4 ]
Quinn, David [5 ]
Walker, Roderick [6 ]
Winstanley, Mark [7 ]
Weickhardt, Andrew [8 ]
Hanning, Fritha [9 ]
Stevanovic, Amanda [10 ]
Davis, Ian [11 ]
Toner, Guy [12 ]
Grimison, Peter [13 ]
机构
[1] NHMRC Clin Trials Ctr, Camperdown, NSW, Australia
[2] Prince Wales Hosp, Med Oncol, Sydney, NSW, Australia
[3] Cambridge Univ Hosp NHS Fdn Trust, Med Oncol, Cambridge, England
[4] Yale Univ, Sch Med, New Haven, CT USA
[5] Univ Southern Calif, Dept Med, Div Canc Med & Blood Dis, Los Angeles, CA USA
[6] Lady Cilento Childrens Hosp, Oncol, Brisbane, Qld, Australia
[7] Auckland Hosp, Starship Childrens Hosp, Auckland, New Zealand
[8] Austin Hosp, Med Oncol, Melbourne, Vic, Australia
[9] Auckland Hosp, Med Oncol, Auckland, New Zealand
[10] Nepean Hosp, Med Oncol, Sydney, NSW, Australia
[11] Monash Univ, Eastern Hlth Clin Sch, Med Oncol, Melbourne, Vic, Australia
[12] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia
[13] Chris OBrien Lifehouse, Med Oncol, Camperdown, SN, Australia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
272
引用
收藏
页码:168 / 168
页数:1
相关论文
共 21 条
  • [21] Multicenter randomized phase 2 trial of paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for first-line treatment of patients (pts) with intermediate- or poor-risk germ cell tumors (GCT).
    Feldman, Darren R.
    Hu, James
    Srinivas, Sandy
    Stadler, Walter Michael
    Costello, Brian Addis
    Appleman, Leonard Joseph
    Milowsky, Matthew I.
    Patil, Sujata
    Bromberg, Maria
    Nolan, Patrick
    Dorff, Tanya B.
    Reuter, Victor E.
    Al-Ahmadie, Hikmat
    Funt, Samuel
    Bajorin, Dean F.
    Bosl, George J.
    Quinn, David I.
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)